Anosmia – The common missing link between Alzheimer’s disease and COVID-19
Open Access
- 27 August 2021
- journal article
- Published by Peertechz Publications Private Limited in Annals of Alzheimer's and Dementia Care
- Vol. 5 (1), 009-010
- https://doi.org/10.17352/aadc.000018
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- COVID-19 and neuropsychiatric disorders: Common links and extended networksJournal of Neurology, Neurological Science and Disorders, 2021
- Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4?Medical Hypotheses, 2021
- Heightened Vulnerability of Alzheimer’s disease in COVID-19 Cataclysm and Putative Management StrategiesAnnals of Alzheimer's and Dementia Care, 2020
- Loss of Smell in COVID-19 Patients: Lessons and OpportunitiesFrontiers in Human Neuroscience, 2020
- Neurobiochemical Cross-talk Between COVID-19 and Alzheimer’s DiseaseMolecular Neurobiology, 2020
- Olfactory Dysfunction as a Global Biomarker for Sniffing out Alzheimer’s Disease: A Meta-AnalysisBiosensors, 2018
- Olfactory Dysfunction Predicts Subsequent Dementia in Older U.S. AdultsJournal of the American Geriatrics Society, 2017
- Interpretation of mushroom as a common therapeutic agent for Alzheimer’s disease and cardiovascular diseasesCritical Reviews in Biotechnology, 2015